Cytosorbents Corp. (CTSO) Stock Continues Climb Following FDA Approval to Conduct STAR-T Trial in U.S
Cytosorbents Corp. (CTSO) stock prices surged by 17.41% as of the market closing on July 6th, 2021, bringing the price per share up to USD$8.63 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock dip by 7.76%, bringing it down to USD$7.96. FDA Approval of IDE Application July 6th, 2021 […]